• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与感染奥密克戎 BA.2.2 的老年患者病毒持续排出相关的因素。

Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2.

机构信息

Department of Neurosurgery, Ninth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Infectious Disease, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Front Public Health. 2023 Jan 12;10:1087800. doi: 10.3389/fpubh.2022.1087800. eCollection 2022.

DOI:10.3389/fpubh.2022.1087800
PMID:36711364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9878338/
Abstract

BACKGROUND

This study explores the risk factors associated with viral shedding time in elderly Chinese patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron.

METHODS

Participants infected with SARS-CoV-2 omicron were enrolled in a retrospective study, and divided into two groups according to shedding time (≥10 days, "late clearance group" and <10 days, "early clearance group").

RESULTS

A total of 180 patients were enrolled in the study (88 early, 92 late), with a median viral shedding time of 10 days and a mean age of 77.02 years. Prolonged SARS-CoV-2 omicron shedding was associated with old age ( = 0.007), lack of vaccination ( = 0.001), delayed admission to hospital after onset of diagnosis ( = 0.001), D-dimer ( = 0.003), and methylprednisolone treatment ( = 0.048). In multivariate analysis, vaccination (OR, 0.319, 95% CI, 0.130-0.786, = 0.013), Paxlovid (OR, 0.259, 95% CI, 0.104-0.643, = 0.004), and time from onset of diagnosis to admission (OR, 1.802, 95% CI, 1.391-2.355, = 0.000) were significantly associated with viral clearance.

CONCLUSIONS

Time from onset of diagnosis to hospitalization, lack of treatment with Paxlovid, and lack of vaccination were independent risk factors in elderly Chinese patients infected with SARS-CoV-2 omicron for prolonged viral shedding.

摘要

背景

本研究旨在探讨与感染严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 奥密克戎的老年中国患者病毒脱落时间相关的危险因素。

方法

本研究纳入了感染 SARS-CoV-2 奥密克戎的患者,采用回顾性研究方法,根据病毒脱落时间(≥10 天,“迟清除组”和<10 天,“早清除组”)将患者分为两组。

结果

共纳入 180 例患者(早清除组 88 例,迟清除组 92 例),中位病毒脱落时间为 10 天,平均年龄为 77.02 岁。SARS-CoV-2 奥密克戎病毒脱落时间延长与年龄较大( = 0.007)、未接种疫苗( = 0.001)、确诊后入院延迟( = 0.001)、D-二聚体( = 0.003)和甲泼尼龙治疗( = 0.048)有关。多变量分析显示,接种疫苗(OR,0.319,95%CI,0.130-0.786, = 0.013)、使用奈玛特韦/利托那韦(OR,0.259,95%CI,0.104-0.643, = 0.004)和从发病到入院的时间(OR,1.802,95%CI,1.391-2.355, = 0.000)与病毒清除显著相关。

结论

从发病到入院的时间、缺乏奈玛特韦/利托那韦治疗以及未接种疫苗是感染 SARS-CoV-2 奥密克戎的老年中国患者病毒持续脱落的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e887/9878338/e4a42ceebbec/fpubh-10-1087800-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e887/9878338/93f0f0e49be5/fpubh-10-1087800-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e887/9878338/e4a42ceebbec/fpubh-10-1087800-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e887/9878338/93f0f0e49be5/fpubh-10-1087800-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e887/9878338/e4a42ceebbec/fpubh-10-1087800-g0002.jpg

相似文献

1
Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2.与感染奥密克戎 BA.2.2 的老年患者病毒持续排出相关的因素。
Front Public Health. 2023 Jan 12;10:1087800. doi: 10.3389/fpubh.2022.1087800. eCollection 2022.
2
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病(COVID-19)患者病毒RNA长期脱落的相关因素
Clin Infect Dis. 2020 Jul 28;71(15):799-806. doi: 10.1093/cid/ciaa351.
3
Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.COVID-19 患者中 SARS-CoV-2 病毒持续排出与阿比多尔治疗开始延迟和就诊时间推迟有关:一项回顾性队列研究。
Curr Med Sci. 2021 Dec;41(6):1096-1104. doi: 10.1007/s11596-021-2434-y. Epub 2021 Sep 13.
4
Clinical predictors and RT-PCR profile of prolonged viral shedding in patients with SARS-CoV-2 Omicron variant in Shanghai: A retrospective observational study.上海 SARS-CoV-2 奥密克戎变异株患者病毒持续排出的临床预测因素和 RT-PCR 特征:一项回顾性观察研究。
Front Public Health. 2022 Oct 24;10:1015811. doi: 10.3389/fpubh.2022.1015811. eCollection 2022.
5
The efficacy of paxlovid in elderly patients infected with SARS-CoV-2 omicron variants: Results of a non-randomized clinical trial.帕罗韦德对感染新型冠状病毒奥密克戎变异株老年患者的疗效:一项非随机临床试验的结果
Front Med (Lausanne). 2022 Sep 6;9:980002. doi: 10.3389/fmed.2022.980002. eCollection 2022.
6
Factors associated with prolonged viral shedding of SARS-CoV-2 Omicron variant infection in Shanghai: A multicenter, retrospective, observational study.与上海 SARS-CoV-2 奥密克戎变异株感染病毒持续排出相关的因素:一项多中心、回顾性、观察性研究。
J Med Virol. 2023 Dec;95(12):e29342. doi: 10.1002/jmv.29342.
7
Comorbidities prolonged viral shedding of patients infected with SARS-CoV-2 omicron variant in Shanghai: A multi-center, retrospective, observational study.上海一项多中心、回顾性、观察性研究显示,合并症使感染 SARS-CoV-2 奥密克戎变异株的患者病毒脱落时间延长。
J Infect Public Health. 2023 Feb;16(2):182-189. doi: 10.1016/j.jiph.2022.12.003. Epub 2022 Dec 6.
8
Clinical characteristics and risk factors analysis of viral shedding time in mildly symptomatic and asymptomatic patients with SARS-CoV-2 Omicron variant infection in Shanghai.上海地区 SARS-CoV-2 奥密克戎变异株感染轻症和无症状患者病毒脱落时间的临床特征及影响因素分析。
Front Public Health. 2023 Jan 4;10:1073387. doi: 10.3389/fpubh.2022.1073387. eCollection 2022.
9
Risk factors for prolonged virus shedding of respiratory tract and fecal in adults with severe acute respiratory syndrome coronavirus-2 infection.成人严重急性呼吸综合征冠状病毒 2 感染患者呼吸道和粪便病毒持续排出的危险因素。
J Clin Lab Anal. 2021 Sep;35(9):e23923. doi: 10.1002/jcla.23923. Epub 2021 Aug 13.
10
Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.与 SARS-CoV-2 感染住院非重症患者病毒持续排出相关因素及洛匹那韦/利托那韦治疗的影响。
Eur Respir J. 2020 Jul 16;56(1). doi: 10.1183/13993003.00799-2020. Print 2020 Jul.

引用本文的文献

1
Successful Sequential Treatment From Remdesivir to Molnupiravir for Prolonged COVID-19 in a Patient With Follicular Lymphoma and Renal Pelvic Carcinoma: A Case Report.一名滤泡性淋巴瘤和肾盂癌患者新冠病毒疾病长期不愈,从瑞德西韦序贯治疗转为莫努匹拉韦治疗成功:病例报告
Cureus. 2024 Dec 15;16(12):e75722. doi: 10.7759/cureus.75722. eCollection 2024 Dec.
2
Efficacy of azvudine plus dexamethasone in severe hospitalized patients with Omicron infection: a prospective multicenter study.阿兹夫定联合地塞米松治疗奥密克戎感染重症住院患者的疗效:一项前瞻性多中心研究
Front Cell Infect Microbiol. 2024 Nov 22;14:1390098. doi: 10.3389/fcimb.2024.1390098. eCollection 2024.
3

本文引用的文献

1
Lessons from SARS‑CoV‑2 and its variants (Review).SARS-CoV-2 及其变体的教训(综述)。
Mol Med Rep. 2022 Aug;26(2). doi: 10.3892/mmr.2022.12779. Epub 2022 Jun 22.
2
[Analysis of clinical characteristics of 362 vaccinated or unvaccinated patients infected by novel coronavirus Omicron variant].[362例接种或未接种新型冠状病毒奥密克戎变异株感染患者的临床特征分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 May;34(5):459-464. doi: 10.3760/cma.j.cn121430-20220223-00167.
3
SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants.
Advancing COVID-19 diagnostics: rapid detection of intact SARS-CoV-2 using viability RT-PCR assay.
推进 COVID-19 诊断:使用存活 RT-PCR 检测法快速检测完整的 SARS-CoV-2。
Microbiol Spectr. 2024 Sep 3;12(9):e0016024. doi: 10.1128/spectrum.00160-24. Epub 2024 Jul 22.
4
Omicron variant and pulmonary involvements: a chest imaging analysis in asymptomatic and mild COVID-19.奥密克戎变异株与肺部受累:无症状和轻症 COVID-19 的胸部影像学分析。
Front Public Health. 2024 Jul 4;12:1325474. doi: 10.3389/fpubh.2024.1325474. eCollection 2024.
5
Association of clinical characteristics and vaccines with risk of persistently viral clearance in patients infected with SARS-CoV-2 Omicron variant in Shanghai, China.中国上海感染新冠病毒奥密克戎变异株患者的临床特征和疫苗与病毒持续清除风险的关联
Heliyon. 2023 Dec 8;10(1):e23256. doi: 10.1016/j.heliyon.2023.e23256. eCollection 2024 Jan 15.
6
During the Omicron Pandemic Wave, the Severe Systemic Inflammatory Status of COVID-19 Indicated a Higher Risk of In-Hospital Mortality and Mediated the Clinical Efficacy of Corticosteroids.在奥密克戎大流行期间,新冠病毒病的严重全身炎症状态表明住院死亡率较高,并介导了皮质类固醇的临床疗效。
Infect Drug Resist. 2023 Nov 30;16:7377-7387. doi: 10.2147/IDR.S432679. eCollection 2023.
7
The differences in virus shedding time between the Delta variant and original SARS-CoV-2 infected patients.德尔塔变异株与原始 SARS-CoV-2 感染患者病毒脱落时间的差异。
Front Public Health. 2023 Jul 24;11:1132643. doi: 10.3389/fpubh.2023.1132643. eCollection 2023.
8
Age-specific transmission dynamics under suppression control measures during SARS-CoV-2 Omicron BA.2 epidemic.奥密克戎 BA.2 流行期间抑制控制措施下的特定年龄传播动力学。
BMC Public Health. 2023 Apr 22;23(1):743. doi: 10.1186/s12889-023-15596-w.
奥密克戎变异株的 SARS-CoV-2 再感染率高于阿尔法和德尔塔变异株。
Ir J Med Sci. 2023 Apr;192(2):751-756. doi: 10.1007/s11845-022-03060-4. Epub 2022 Jun 17.
4
Risk Factors for COVID-19 Hospitalization in School-Age Children.学龄儿童新冠病毒感染住院的风险因素
Health Serv Res Manag Epidemiol. 2022 Jun 9;9:23333928221104677. doi: 10.1177/23333928221104677. eCollection 2022 Jan-Dec.
5
Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2.感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变异株的2019冠状病毒病(COVID-19)患者的临床特征
Front Med (Lausanne). 2022 May 9;9:912367. doi: 10.3389/fmed.2022.912367. eCollection 2022.
6
An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants.一项关于VV116 在中国感染 SARS-CoV-2 奥密克戎变异株的参与者中的开放、前瞻性队列研究。
Emerg Microbes Infect. 2022 Dec;11(1):1518-1523. doi: 10.1080/22221751.2022.2078230.
7
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2.奥密克戎 BA.2 型 SARS-CoV-2 的特征和抗病毒敏感性
Nature. 2022 Jul;607(7917):119-127. doi: 10.1038/s41586-022-04856-1. Epub 2022 May 16.
8
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance.SARS-CoV-2 奥密克戎变异株:流行病学特征、生物学特性及临床意义。
Front Immunol. 2022 Apr 29;13:877101. doi: 10.3389/fimmu.2022.877101. eCollection 2022.
9
SARS-CoV-2 Omicron variant: recent progress and future perspectives.SARS-CoV-2 奥密克戎变异株:最新进展与未来展望。
Signal Transduct Target Ther. 2022 Apr 28;7(1):141. doi: 10.1038/s41392-022-00997-x.
10
The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads.德尔塔变异株被奥密克戎取代:对住院和上呼吸道病毒载量的调查。
EBioMedicine. 2022 May;79:104008. doi: 10.1016/j.ebiom.2022.104008. Epub 2022 Apr 20.